1. Home
  2. RLAY

RLAY

Relay Therapeutics Inc.

as 04-18-2025 1:42pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Founded: 2015 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: N/A IPO Year: 2020
Target Price: $19.33 AVG Volume (30 days): 3.0M
Analyst Decision: Strong Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.36 EPS Growth: N/A
52 Week Low/High: $1.77 - $10.72 Next Earning Date: 05-01-2025
Revenue: $10,007,000 Revenue Growth: -60.83%
Revenue Growth (this year): -57.01% Revenue Growth (next year): 420.18%

RLAY Daily Stock ML Predictions

Stock Insider Trading Activity of Relay Therapeutics Inc. (RLAY)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Bergstrom Donald A RLAY President, R&D Mar 27 '25 Sell $2.84 986 $2,800.24 615,052
Adams Brian RLAY Chief Legal Officer Mar 27 '25 Sell $2.84 298 $846.32 405,972
Catinazzo Thomas RLAY Chief Financial Officer Mar 27 '25 Sell $2.84 4,864 $13,813.76 374,567
Rahmer Peter RLAY See remarks Mar 27 '25 Sell $2.84 247 $701.48 402,184
Patel Sanjiv RLAY President and CEO Feb 11 '25 Sell $3.78 215,506 $818,399.50 625,948
Bergstrom Donald A RLAY President, R&D Jan 28 '25 Sell $4.53 80,450 $362,298.11 615,052
Adams Brian RLAY Chief Legal Officer Jan 28 '25 Sell $4.53 54,479 $247,871.66 405,972
Catinazzo Thomas RLAY Chief Financial Officer Jan 28 '25 Sell $4.56 58,936 $268,338.85 374,567
Rahmer Peter RLAY See remarks Jan 28 '25 Sell $4.53 45,464 $204,752.54 402,184
Patel Sanjiv RLAY President and CEO Jan 21 '25 Sell $4.70 375,000 $1,762,500.00 625,948

Share on Social Networks: